As reported previously, treatment with CMs from tumour cells activated Hs738 cells (Fig. 4a), and enhanced IL-8 levels (Fig. 4b), and KDM5B levels were increased accordingly (Fig. 4a). This evidence concerns the gene CXCL8 and neoplasm.